Nitroglycerin sublingual - Pfizer
Alternative Names: NitrostatLatest Information Update: 02 Oct 2021
At a glance
- Originator Parke-Davis Pharmaceutical Division
- Developer Parke-Davis Pharmaceutical Division; Pfizer
- Class Antineoplastics; Erectile dysfunction therapies; Heart failure therapies; Ischaemic heart disorder therapies; Nitro compounds; Organic nitrates; Small molecules; Sugar alcohols; Vasodilators
- Mechanism of Action Guanylate cyclase stimulants; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Angina pectoris
Most Recent Events
- 03 Jul 2019 Chemical structure information added
- 29 Nov 2017 Launched for Angina pectoris in Canada (Sublingual) before November 2017
- 29 Nov 2017 Launched in Angina pectoris in China (Sublingual) before November 2017